Chiasma Inc (NASDAQ:CHMA) Slain By A Late-Night Negative FDA Response
[[tagnumber 0]][[tagnumber 1]]Last Friday, the U.S. Food And Drug Administration (the FDA) refused to give approval to Chiasma Inc‘s (NASDAQ:CHMA) recently filed new drug application for Mycapssa (octreotide) capsules for the maintenance treatment of...